Top Markets
#1 Islamic Coin Islamic Coin +154.41%
#2 PulseChain PulseChain +49.22%
#3 BOOK OF MEME BOOK OF MEME +24.55%
#4 RedStone RedStone +19.62%
#5 Starpower Starpower +15.19%
#6 Lighter Lighter +13.41%
#7 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.95%
#8 SkyAI SkyAI +10.69%
#9 Monad Monad +10.55%
#10 Venom Venom +9.87%
Coin of the day
Islamic Coin Islamic Coin
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Neurizon Therapeutics Limited Neurizon Therapeutics Limited

Neurizon Therapeutics Limited

NUZ
Clasificación en acciones #27538
Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops... Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Precio por acción
$0.0416118
Capitalización bursátil
$32.25M
Cambio (1 día)
-1.67%
Cambio (1 año)
-59.58%
País
AU
Comercio Neurizon Therapeutics Limited (NUZ)

Categoría

Healthcare
Ganancias de Neurizon Therapeutics Limited (NUZ)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Neurizon Therapeutics Limited, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Neurizon Therapeutics Limited desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH